Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Presentation THT 2025

Impact of Hemodynamic Testing and Pulmonary Artery Pressure Monitoring on HeartMate 3 RPM and Medication Adjustments: RAMP-IT-UP 3 Study

Presenter: Dor Lotan

February 12, 2025

Presentation THT 2025

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Presenter: Nir Uriel

February 12, 2025

Presentation THT 2025

Incidence and Outcome of Early and Late Right Ventricular Failure in Patients with the HeartMate 3 LVAD: A MOMENTUM 3 Analysis

Presenter: Gabriel Sayer

February 11, 2025

Presentation THT Abstracts 2024

Does Guideline-Directed Medical Therapy Improve Outcomes in HeartMate 3 Patients?

Presenter: Julia Baranowska

March 05, 2024

Presentation THT Abstracts 2024

Central and Peripheral Determinants of Exercise with the HeartMate 3TM LVAD

Presenter: David Golombeck

March 05, 2024

Presentation THT Abstracts 2024

Guideline-Directed Heart Failure Therapy in HeartMate 3 Patients

Presenter: Changhee Lee

March 05, 2024

Presentation THT 2024

Decathlon: In it for the Long Run - What are the Next Steps with HeartMate 3 LVAD Therapy?

Presenter: Jennifer A. Cowger

March 05, 2024

Presentation THT 2024

Decade: 10 years and Counting Since the First HeartMate 3 LVAD Implantation - What have we Learned?

Presenter: Nir Uriel

March 05, 2024

Presentation THT 2023

HeartMate 3 LVAD beyond MOMENTUM 3 – Where are we now?

Presenter: Scott Silvestry

March 21, 2023

Presentation THT 2023

PREOPERATIVE LIVER DYSFUNCTION PREDICTS RIGHT VENTRICULAR FAILURE FOLLOWING HEARTMATE-3 IMPLANTATION IN A CONTEMPORARY COHORT

Presenter: David Lambert

March 20, 2023

Presentation THT 2022

HeartMate 3 With a Side of Mustard

Presenter: Sheng Fu

February 02, 2022

Presentation TCT 2015

LV to Aorta Pumping: HeartMate PHP

Presenter: Valluvan Jeevanandam, Ulrich P. Jorde

October 14, 2015

Presentation TCT 2015

HeartMate Percutaneous Heart Pump (PHP) in Cardiogenic Shock Initial Clinical Experience From Prague

Presenter: Andrea Abizaid, Daniel Burkhoff, Jiri Maly

October 14, 2015

Presentation TCT 2015

HeartMate Percutaneous Heart Pump (PHP) in High-Risk Coronary Intervention: Results of the SHIELD I Trial

Presenter: Andrea Abizaid, Daniel Burkhoff, Dariusz Dudek

October 14, 2015

Advertisement

Impact of Hemodynamic Testing and Pulmonary Artery Pressure Monitoring on HeartMate 3 RPM and Medication Adjustments: RAMP-IT-UP 3 Study

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Incidence and Outcome of Early and Late Right Ventricular Failure in Patients with the HeartMate 3 LVAD: A MOMENTUM 3 Analysis

Does Guideline-Directed Medical Therapy Improve Outcomes in HeartMate 3 Patients?

Central and Peripheral Determinants of Exercise with the HeartMate 3TM LVAD

Guideline-Directed Heart Failure Therapy in HeartMate 3 Patients

Decathlon: In it for the Long Run - What are the Next Steps with HeartMate 3 LVAD Therapy?

Decade: 10 years and Counting Since the First HeartMate 3 LVAD Implantation - What have we Learned?

HeartMate 3 LVAD beyond MOMENTUM 3 – Where are we now?

PREOPERATIVE LIVER DYSFUNCTION PREDICTS RIGHT VENTRICULAR FAILURE FOLLOWING HEARTMATE-3 IMPLANTATION IN A CONTEMPORARY COHORT

HeartMate 3 With a Side of Mustard

LV to Aorta Pumping: HeartMate PHP

HeartMate Percutaneous Heart Pump (PHP) in Cardiogenic Shock Initial Clinical Experience From Prague

HeartMate Percutaneous Heart Pump (PHP) in High-Risk Coronary Intervention: Results of the SHIELD I Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content